JBC PeproTech; Our Business is Cytokines!

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M706831200 on January 17, 2008

J. Biol. Chem., Vol. 283, Issue 13, 8687-8698, March 28, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/13/8687    most recent
M706831200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Moss, B. L.
Right arrow Articles by Piwnica-Worms, D.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moss, B. L.
Right arrow Articles by Piwnica-Worms, D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Identification of a Ligand-induced Transient Refractory Period in Nuclear Factor-{kappa}B Signaling*

Britney L. Moss{ddagger}12, Shimon Gross{ddagger}1, Seth T. Gammon{ddagger}, Anant Vinjamoori{ddagger}, and David Piwnica-Worms{ddagger}§3

From the {ddagger}Molecular Imaging Center, Mallinckrodt Institute of Radiology, and the §Department of Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, Missouri 63110

In response to a variety of extracellular ligands, nuclear factor-{kappa}B (NF-{kappa}B) signaling regulates inflammation, cell proliferation, and apoptosis. It is likely that cells are not continuously exposed to stimulating ligands in vivo but rather experience transient pulses. To study the temporal regulation of NF-{kappa}B and its major regulator, inhibitor of NF-{kappa}B{alpha} (I{kappa}B{alpha}), in real time, we utilized a novel transcriptionally coupled I{kappa}B{alpha}-firefly luciferase fusion reporter and characterized the dynamics and responsiveness of I{kappa}B{alpha} processing upon a short 30-s pulse of tumor necrosis factor {alpha} (TNF{alpha}) or a continuous challenge of TNF{alpha} following a 30-s preconditioning pulse. Strikingly, a 30-s pulse of TNF{alpha} robustly activated inhibitor of NF-{kappa}B kinase (IKK), leading to I{kappa}B{alpha} degradation, NF-{kappa}B nuclear translocation, and strong transcriptional up-regulation of I{kappa}B{alpha}. Furthermore, we identified a transient refractory period (lasting up to 120 min) following preconditioning, during which the cells were not able to fully degrade I{kappa}B{alpha} upon a second TNF{alpha} challenge. Kinase assays of IKK activity revealed that regulation of IKK activity correlated in part with this transient refractory period. In contrast, experiments involving sequential exposure to TNF{alpha} and interleukin-1β indicated that receptor dynamics could not explain this phenomenon. Utilizing a well accepted computational model of NF-{kappa}B dynamics, we further identified an additional layer of regulation, downstream of IKK, that may govern the temporal capacity of cells to respond to a second proinflammatory insult. Overall, the data suggested that nuclear export of NF-{kappa}B·I{kappa}B{alpha} complexes represented another rate-limiting step that may impact this refractory period, thereby providing an additional regulatory mechanism.


Received for publication, August 16, 2007 , and in revised form, January 8, 2008.

* This work was supported in part by National Institutes of Health Molecular Imaging Center Grant P50 CA94056. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Both authors contributed equally to this work.

2 Supported in part by a National Science Foundation graduate research fellowship grant.

3 To whom correspondence should be addressed: Mallinckrodt Institute of Radiology, Washington University School of Medicine, 510 S. Kingshighway Blvd., Box 8225, St. Louis, MO 63110. Tel.: 314-362-9359; Fax: 314-362-0152; E-mail: piwnica-wormsd{at}mir.wustl.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.